We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Eli Lilly said Monday that it will launch an authorised generic version of Humalog (insulin lispro) in the US at a 50-percent lower list price than the original branded product as part of efforts to address the issue of patients' high out-of-pocket costs.